These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Treatment outcomes of first-ever episode of severe optic neuritis. Galetta K; Ryan S; Manzano G; Chibnik LB; Balaban D; Prasad S; Chwalisz BK; Salazar-Camelo A; Conway S; Levy M; Matiello M Mult Scler Relat Disord; 2022 Oct; 66():104020. PubMed ID: 35839615 [TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis]. Song HL; Wei SH Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):174-179. PubMed ID: 30841683 [No Abstract] [Full Text] [Related]
13. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study. Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487 [TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment. Gospe SM; Chen JJ; Bhatti MT Eye (Lond); 2021 Mar; 35(3):753-768. PubMed ID: 33323985 [TBL] [Abstract][Full Text] [Related]
15. Isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: The importance of age of onset and prognosis-related radiological features. Zhao J; Chen X; Zhang J; Liu L; Wang J; Zhu L Mult Scler Relat Disord; 2024 May; 85():105518. PubMed ID: 38447395 [TBL] [Abstract][Full Text] [Related]
16. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature. Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort. Dauby S; Dive D; Lutteri L; Andris C; Hansen I; Maquet P; Lommers E Acta Neurol Belg; 2022 Feb; 122(1):135-144. PubMed ID: 34097296 [TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis. Tajfirouz DA; Bhatti MT; Chen JJ Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369 [TBL] [Abstract][Full Text] [Related]
19. Clinical risk factors for recurrence of myelin oligodendrocyte glycoprotein antibody-associated disease. Wang J; Yang K; Zhang F; Yi Y; Wang J Mult Scler Relat Disord; 2023 Sep; 77():104879. PubMed ID: 37442076 [TBL] [Abstract][Full Text] [Related]
20. Details and outcomes of a large cohort of MOG-IgG associated optic neuritis. Chen JJ; Flanagan EP; Bhatti MT; Tisavipat N; Jamali S; Kunchok A; Eggenberger ER; Nome MD; Sotirchos ES; Vasileiou ES; Henderson AD; Arnold AC; Bonelli L; Seleme N; Mejia-Vergara AJ; Moss HE; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Wilf-Yarkoni A; Hellmann MA; Vuppala A; Hodge D; Pittock SJ Mult Scler Relat Disord; 2022 Dec; 68():104237. PubMed ID: 36252317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]